ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

PALO ALTO, Calif., Jan. 5, 2018 -- (Healthcare Sales & Marketing Network) -- ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Paradise Renal Dener... Devices, Cardiology ReCor Medical, Renal Denervation, hypertension
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news